<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37145596</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post-COVID-19 Condition.</ArticleTitle><Pagination><StartPage>e2311974</StartPage><MedlinePgn>e2311974</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2023.11974</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Neuropsychiatric symptoms are common in acute SARS-CoV-2 infection and in post-COVID-19 condition (PCC; colloquially known as long COVID), but the association between early presenting neuropsychiatric symptoms and PCC is unknown.</AbstractText><AbstractText Label="OBJECTIVE">To describe the characteristics of patients with perceived cognitive deficits within the first 4 weeks of SARS-CoV-2 infection and the association of those deficits with PCC symptoms.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This prospective cohort study was conducted from April 2020 to February 2021, with follow-up of 60 to 90 days. The cohort consisted of adults enrolled in the University of California, Los Angeles, SARS-CoV-2 Ambulatory Program who had a laboratory-confirmed symptomatic SARS-CoV-2 infection and were either hospitalized in a University of California, Los Angeles, hospital or one of 20 local health care facilities, or were outpatients referred by a primary care clinician. Data analysis was performed from March 2022 to February 2023.</AbstractText><AbstractText Label="EXPOSURE">Laboratory-confirmed SARS-CoV-2 infection.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Patients responded to surveys that included questions about perceived cognitive deficits modified from the Perceived Deficits Questionnaire, Fifth Edition, (ie, trouble being organized, trouble concentrating, and forgetfulness) and symptoms of PCC at 30, 60, and 90 days after hospital discharge or initial laboratory-confirmed infection of SARS-CoV-2. Perceived cognitive deficits were scored on a scale from 0 to 4. Development of PCC was determined by patient self-report of persistent symptoms 60 or 90 days after initial SARS-CoV-2 infection or hospital discharge.</AbstractText><AbstractText Label="RESULTS">Of 1296 patients enrolled in the program, 766 (59.1%) (mean [SD] age, 60.0 [16.7] years; 399 men [52.1%]; 317 Hispanic/Latinx patients [41.4%]) completed the perceived cognitive deficit items at 30 days after hospital discharge or outpatient diagnosis. Of the 766 patients, 276 (36.1%) perceived a cognitive deficit, with 164 (21.4%) having a mean score of greater than 0 to 1.5 and 112 patients (14.6 %) having a mean score greater than 1.5. Prior cognitive difficulties (odds ratio [OR], 1.46; 95% CI, 1.16-1.83) and diagnosis of depressive disorder (OR, 1.51; 95% CI, 1.23-1.86) were associated with report of a perceived cognitive deficit. Patients reporting perceived cognitive deficits in the first 4 weeks of SARS-CoV-2 infection were more likely to report symptoms of PCC than those without perceived cognitive deficits (118 of 276 patients [42.8%] vs 105 of 490 patients [21.4%]; &#x3c7;21, 38.9; P&#x2009;&lt;&#x2009;.001). Adjusting for demographic and clinical factors, perceived cognitive deficits in the first 4 weeks of SARS-CoV-2 were associated with PCC symptoms (patients with a cognitive deficit score of &gt;0 to 1.5: OR, 2.42; 95% CI, 1.62-3.60; patients with cognitive deficit score &gt;1.5: OR, 2.97; 95% CI, 1.86-4.75) compared to patients who reported no perceived cognitive deficits.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">These findings suggest that patient-reported perceived cognitive deficits in the first 4 weeks of SARS-CoV-2 infection are associated with PCC symptoms and that there may be an affective component to PCC in some patients. The underlying reasons for PCC merit additional exploration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Teresa C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine &amp; Health Services Research, Department of Medicine, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Sun M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine &amp; Health Services Research, Department of Medicine, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim</LastName><ForeName>Myung S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Medicine Statistics Core, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motwani</LastName><ForeName>Yash</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine Statistics Core, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viswanathan</LastName><ForeName>Nisha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine &amp; Health Services Research, Department of Medicine, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wenger</LastName><ForeName>Neil S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine &amp; Health Services Research, Department of Medicine, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001881</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> None reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>5</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>5</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37145596</ArticleId><ArticleId IdType="mid">NIHMS1947968</ArticleId><ArticleId IdType="pmc">PMC10715897</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.11974</ArticleId><ArticleId IdType="pii">2804555</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Disease Control and Prevention. Long-COVID or post-COVID conditions. Accessed October 14, 2022.https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html</Citation></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604&#x2013;1615. doi:10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, van Jaarsveld CHM. Post-acute and long-COVID-19symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022;39(1):159&#x2013;167. doi:10.1093/fampra/cmab076</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak KW, Johnsen S, Sattler SM, et al. Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39&#x2013;48. doi:10.1016/j.euroneuro.2021.03.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. 2021;8(5):1073&#x2013;1085. doi:10.1002/acn3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmuth J, Barnett TA, Asken BM, et al. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J Neurovirol. 2021;27(1):191&#x2013;195. doi:10.1007/s13365-021-00954-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00954-4</ArticleId><ArticleId IdType="pmc">PMC7852463</ArticleId><ArticleId IdType="pubmed">33528824</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaywant A, Vanderlind WM, Alexopoulos GS, Fridman CB, Perlis RH, Gunning FM. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021; 46(13):2235&#x2013;2240. doi:10.1038/s41386-021-00978-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-021-00978-8</ArticleId><ArticleId IdType="pmc">PMC7884062</ArticleId><ArticleId IdType="pubmed">33589778</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, Chen Y, Wang QH, et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol. 2022;79(5):509&#x2013;517. doi:10.1001/jamaneurol.2022.0461</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.0461</ArticleId><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374(1648):n1648. doi:10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi:10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert NJ. Survivor Corps. COVID-19 &#x201c;long hauler&#x201d; symptoms survey report. Indiana University School ofMedicine; 2020. Accessed October 14, 2022. https://dig.abclocal.go.com/wls/documents/2020/072720-wls-covid-symptom-study-doc.pdf</Citation></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4&#x2013;e6. doi:10.1016/j.jinf.2020.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. 2021;4(1):e2036142. doi:10.1001/jamanetworkopen.2020.36142</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi:10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27(1):89&#x2013;95. doi:10.1016/j.cmi.2020.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyraz B&#xc7;, Poyraz CA, Olgun Y, et al. Psychiatric morbidity and protracted symptoms after COVID-19. Psychiatry Res. 2021;295:113604. doi:10.1016/j.psychres.2020.113604</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113604</ArticleId><ArticleId IdType="pmc">PMC7695976</ArticleId><ArticleId IdType="pubmed">33296818</ArticleId></ArticleIdList></Reference><Reference><Citation>Daroische R, Hemminghyth MS, Eilertsen TH, Breitve MH, Chwiszczuk LJ. Cognitive impairment after COVID-19: a review on objective test data. Front Neurol. 2021;12:699582. doi:10.3389/fneur.2021.699582</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.699582</ArticleId><ArticleId IdType="pmc">PMC8357992</ArticleId><ArticleId IdType="pubmed">34393978</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C, Valles-Salgado M, Delgado-&#xc1;lvarez A, et al. Cognitive dysfunction associated with COVID-19: a comprehensive neuropsychological study. J Psychiatr Res. 2022;150:40&#x2013;46. doi:10.1016/j.jpsychires.2022.03.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.03.033</ArticleId><ArticleId IdType="pmc">PMC8943429</ArticleId><ArticleId IdType="pubmed">35349797</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044. doi:10.1016/j.eclinm.2021.101044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al.; IVY Network Investigators; CDC COVID-19 Response Team; Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993&#x2013;998. doi:10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackett JW, Wainberg M, Elkind MSV, Freedberg DE. Potential long coronavirus disease 2019 gastrointestinal symptoms 6 months after coronavirus infection are associated with mental health symptoms. Gastroenterology. 2022;162(2):648&#x2013;650.e2. doi:10.1053/j.gastro.2021.10.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.040</ArticleId><ArticleId IdType="pmc">PMC8556689</ArticleId><ArticleId IdType="pubmed">34728186</ArticleId></ArticleIdList></Reference><Reference><Citation>Garjani A, Middleton RM, Nicholas R, Evangelou N. Recovery from COVID-19 in multiple sclerosis: a prospective and longitudinal cohort study of the United Kingdom Multiple Sclerosis Register. Neurol Neuroimmunol Neuroinflamm. 2021;9(1):e1118. doi:10.1212/NXI.0000000000001118</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001118</ArticleId><ArticleId IdType="pmc">PMC8631790</ArticleId><ArticleId IdType="pubmed">34848503</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, et al. Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post-COVID-19 conditions. JAMA Psychiatry. 2022;79(11):1081&#x2013;1091. doi:10.1001/jamapsychiatry.2022.2640</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.2640</ArticleId><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo SM, Liu TC, Motwani Y, et al. Factors associated with post-acute sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic COVID-19 in the inpatient and outpatient setting in a diverse cohort. J Gen Intern Med. 2022;37(8):1988&#x2013;1995. doi:10.1007/s11606-022-07523-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07523-3</ArticleId><ArticleId IdType="pmc">PMC8989256</ArticleId><ArticleId IdType="pubmed">35391623</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573&#x2013;577. doi:10.7326/0003-4819-147-8-200710160-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-147-8-200710160-00010</ArticleId><ArticleId IdType="pubmed">17938396</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473&#x2013;483. doi:10.1097/00005650-199206000-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199206000-00002</ArticleId><ArticleId IdType="pubmed">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha D Perceived deficits questionnaire&#x2014;depression, 5-item (PDQ-D-5). In: McIntyre R, ed. Cognitive Impairment in Major Depressive Disorder: Clinical Relevance, Biological Substrates, and Treatment Opportunities. Cambridge University Press; 2016:253&#x2013;256.</Citation></Reference><Reference><Citation>Strober LB, Binder A, Nikelshpur OM, Chiaravalloti N, DeLuca J. The Perceived Deficits Questionnaire: perception, deficit, or distress? Int J MS Care. 2016;18(4):183&#x2013;190. doi:10.7224/1537-2073.2015-028</Citation><ArticleIdList><ArticleId IdType="doi">10.7224/1537-2073.2015-028</ArticleId><ArticleId IdType="pmc">PMC4984790</ArticleId><ArticleId IdType="pubmed">27551243</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan MJ, Hall E, Bartolacci R, Sullivan ME, Adams H. Perceived cognitive deficits, emotional distress and disability following whiplash injury. Pain Res Manag. 2002;7(3):120&#x2013;126. doi:10.1155/2002/502984</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2002/502984</ArticleId><ArticleId IdType="pubmed">12420020</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson NR, Fan Y, Dalton JE, et al. A new Elixhauser-based comorbidity summary measure to predict in-hospital mortality. Med Care. 2015;53(4):374&#x2013;379. doi:10.1097/MLR.0000000000000326</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0000000000000326</ArticleId><ArticleId IdType="pmc">PMC4812819</ArticleId><ArticleId IdType="pubmed">25769057</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention; Agency for Toxic Substances and Disease Registry. CDC/ATSDRSocial Vulnerability Index. 2021. Accessed October 14, 2022. https://www.atsdr.cdc.gov/placeandhealth/svi/data_documentation_download.html</Citation></Reference><Reference><Citation>Mcloughlin BC, Miles A, Webb TE, et al. Functional and cognitive outcomes after COVID-19 delirium. Eur Geriatr Med. 2020;11(5):857&#x2013;862. doi:10.1007/s41999-020-00353-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41999-020-00353-8</ArticleId><ArticleId IdType="pmc">PMC7358317</ArticleId><ArticleId IdType="pubmed">32666303</ArticleId></ArticleIdList></Reference><Reference><Citation>Manca R, De Marco M, Ince PG, Venneri A. heterogeneity in regional damage detected by neuroimaging and neuropathological studies in older adults with COVID-19: a cognitive-neuroscience systematic review to inform the long-term impact of the virus on neurocognitive trajectories. Front Aging Neurosci. 2021;13:646908. doi:10.3389/fnagi.2021.646908</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.646908</ArticleId><ArticleId IdType="pmc">PMC8209297</ArticleId><ArticleId IdType="pubmed">34149394</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697&#x2013;707. doi:10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackin RS, Are&#xe1;n PA. Incidence and documentation of cognitive impairment among older adults with severe mental illness in a community mental health setting. Am J Geriatr Psychiatry. 2009;17(1):75&#x2013;82. doi:10.1097/JGP.0b013e31818cd3e5</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JGP.0b013e31818cd3e5</ArticleId><ArticleId IdType="pmc">PMC3239216</ArticleId><ArticleId IdType="pubmed">19092314</ArticleId></ArticleIdList></Reference><Reference><Citation>Cully JA, Jimenez DE, Ledoux TA, Deswal A. Recognition and treatment of depression and anxiety symptoms in heart failure. Prim Care Companion J Clin Psychiatry. 2009;11(3):103&#x2013;109. doi:10.4088/PCC.08m00700</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/PCC.08m00700</ArticleId><ArticleId IdType="pmc">PMC2708006</ArticleId><ArticleId IdType="pubmed">19617942</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>